Peter Mcnamara
Chief Scientific Officer at Tectonic Therapeutic, Inc. (TECX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $288K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 53654,305 held (−1%) | $23.04 | $12K | +1.3% |
| Aug 26SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 4355,285 held (−0%) | $36.52 | $2K | -36.1% |
| Aug 14SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 4355,285 held (−0%) | $35.00 | $2K | -33.3% |
| Jul 1SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 17255,285 held (−0%) | $35.00 | $6K | -33.3% |
| Mar 9SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 6,04755,500 held (−10%) | $30.00 | $181K | -22.2% |
| Mar 9SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 21555,285 held (−0%) | $35.00 | $8K | -33.3% |
| Mar 5SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 1,64937,482 held (−4%) | $22.06 | $36K | +5.8% |
| Mar 5SEC | TECXTectonic Therapeutic, Inc. | Sell Plan | 1,65058,832 held (−3%) | $25.00 | $41K | -6.7% |
- Sell
Chief Scientific Officer Peter Mcnamara sold $12K of TECX at $23.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Peter Mcnamara sold $2K of TECX at $36.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Peter Mcnamara sold $2K of TECX at $35.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Peter Mcnamara sold $6K of TECX at $35.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Peter Mcnamara sold $181K of TECX at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Peter Mcnamara sold $8K of TECX at $35.00 — pre-scheduled 10b5-1 plan sale.